Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Sucampo Pharmaceuticals (SCMP)

Add to Watchlists
Create an Alert
6.84 -0.02  -0.29% NASDAQ Apr 23, 10:59AM BATS Real time Currency in USD
View Full Chart
SCMP Price Chart
View All Events

SCMP Events

Date Type Description
Feb 26 Misc Sucampo Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Feb 26 Earnings Sucampo Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: 0.00.
Nov 05 Misc Q3 2013 Sucampo Pharmaceuticals, Inc. Earnings Conference Call
Nov 05 Earnings Q3 2013 Sucampo Pharmaceuticals, Inc. Earnings Results. Estimate: -0.03.
Aug 08 Misc Sucampo Pharmaceuticals Announces Second Quarter and Six Months 2013 Results and Operating Highlights Teleconference and Webcast
Aug 08 Earnings Q2 2013 Sucampo Pharmaceuticals, Inc. Earnings. Estimate: 0.14.
May 22 Misc AGM Event for Sucampo Pharmaceuticals Inc
May 07 Misc Sucampo Pharmaceuticals Announces First Quarter 2013 Results and Operating Highlights Teleconference and Webcast
May 07 Earnings Sucampo Pharmaceuticals Announces First Quarter 2013 Results. Estimate: -0.02.
View All Performance Charts

SCMP Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sucampo Pharmaceuticals is up 0.29% over the last year vs S&P 500 Total Return up 22.75%, Forest Laboratories up 154.8%, and Takeda Pharmaceutical down 15.14%.

Get Quote for
Advertisement

Portfolio Strategies Featuring SCMP

Did Sucampo Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SCMP Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company engaged in research, development & sale of proprietary drugs based on ion channel activators known as prostones to treat gastrointestinal, neurologic, & oncology-based inflammatory disorders.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SCMP 6.84 -0.02 -0.29% 296.28M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.